Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population

References

• Matsushita K, Ballew SH, Coresh J. Cardiovascular risk prediction in people with chronic kidney disease. Curr Opin Nephrol Hypertens. 2016;25(6):518–523.
   PubMedGoogle Scholar
• Webster AC, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl. 2005;94:S63–7.
   Google Scholar
• Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int. 2004;66(4):1310–1314.
   PubMed Web of Science ®Google Scholar
• Gnudi L, Coward R, Long DA. Diabetic nephropathy: perspective on novel molecular mechanisms. Trends Endocrinol Metab. 2016;27(11):820–830.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–23.
   PubMed Web of Science ®Google Scholar
• Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15–26.
   PubMed Web of Science ®Google Scholar
• Amato MC, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–922.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I, Daimon T. A strong association between lipid accumulation product and diabetes mellitus in japanese women and men. J Atheroscler Thromb. 2014;21(3):282–288.
   PubMedGoogle Scholar
• Mazidi M, Kengne AP, Katsiki N, et al. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complications. 2018;32(3):266–270.
   PubMed Web of Science ®Google Scholar
• Elizalde-Barrera CI, et al. Triglycerides and waist to height ratio are more accurate than visceral adiposity and body adiposity index to predict impaired fasting glucose. Diabetes Res Clin Pract. 2019;153:49–54.
   PubMedGoogle Scholar
• Ahn N, Baumeister SE, Amann U, et al. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Sci Rep. 2019;9(1):9693.
   PubMedGoogle Scholar
• Brahimaj A, Rivadeneira F, Muka T, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62(9):1581–1590.
   PubMed Web of Science ®Google Scholar
• Nascimento-Ferreira MV, Rendo-Urteaga T, Vilanova-Campelo RC, et al. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults. Clin Nutr. 2017;36(6):1693–1700.
   PubMed Web of Science ®Google Scholar
• Dai D, Chang Y, Chen Y, et al. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in Northeast China. Int J Environ Res Public Health. 2016;13:12.
   Google Scholar
• Shi W, et al. Estimate of reduced glomerular filtration rate by triglyceride-glucose index: insights from a general Chinese population. Postgrad Med. 2019;131(4):287–294.
   PubMed Web of Science ®Google Scholar
• Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
   PubMedGoogle Scholar
• Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.
   PubMedGoogle Scholar
• Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab. 2002;87(11):5044–5051.
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944.
   PubMed Web of Science ®Google Scholar
• Shively CA, Register TC, Clarkson TB. Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol. 2009;71(9):742–751.
   PubMed Web of Science ®Google Scholar
• Yu S, Yang H, Guo X, Zheng L, Sun Y. Association between obese phenotype and mildly reduced eGFR among the General Population from Rural Northeast China. Int J Environ Res Public Health. 2016;13:6.
   Web of Science ®Google Scholar
• Stepien M, Stępień A, Wlazeł RN, et al. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease. Med Sci Monit. 2013;19:1063–1072.
   PubMedGoogle Scholar
• Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23(4):465–471.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, et al. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–60.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308(11):1150–1159.
   PubMed Web of Science ®Google Scholar
• Kim SR, Yoo JH, Song HC, et al. Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transplant. 2011;26(11):3550–3555.
   PubMedGoogle Scholar
• DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001;24(5):925–932.
   PubMedGoogle Scholar
• Kwakernaak AJ, Zelle DM, Bakker SJ, et al. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol. 2013;24(6):987–994.
   PubMedGoogle Scholar
• Roubicek T, Bartlova M, Krajickova J, et al. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition. 2009;25(7–8):762–768.
   PubMedGoogle Scholar
• Dave N, Wu J, Thomas S. Chronic kidney disease-induced insulin resistance: current state of the field. Curr Diab Rep. 2018;18(7):44.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801.
   PubMed Web of Science ®Google Scholar
• Tansey JT, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A. 2001;98(11):6494–6499.
   PubMed Web of Science ®Google Scholar
• Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005;16(4):1091–1098.
   PubMed Web of Science ®Google Scholar
• Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998;53(5):1343–1347.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis. 2005;45(2):275–280.
   PubMed Web of Science ®Google Scholar
• Fragoso A, et al. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease. J Diabetes Complications. 2015;29(8):1098–1104.
   PubMed Web of Science ®Google Scholar
• Cornier MA, Despres JP, Davis N, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011;124(18):1996–2019.
   PubMed Web of Science ®Google Scholar
• Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
   PubMedGoogle Scholar
• Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring). 2013;21(8):1690–1694.
   PubMed Web of Science ®Google Scholar
• Tripathy JP, JS Thakur, G Jeet, et al. Urban rural differences in diet, physical activity and obesity in India: are we witnessing the great Indian equalisation? Results from a cross-sectional STEPS survey. BMC Public Health. 2016;16(1):816.
   PubMedGoogle Scholar
• Zhang XH, et al. Comparison of anthropometric and atherogenic indices as screening tools of metabolic syndrome in the Kazakh Adult Population in Xinjiang. Int J Environ Res Public Health. 2016;13(4):428.
   PubMed Web of Science ®Google Scholar
• Vasques AC, Novaes FS, de Oliveira MD, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100.
   PubMed Web of Science ®Google Scholar
• Mikhail N. The metabolic syndrome: insulin resistance. Curr Hypertens Rep. 2009;11(2):156–158.
   PubMed Web of Science ®Google Scholar
• Eckel RH, et al. The metabolic syndrome. Lancet. 2010;375(9710):181–183.
   PubMed Web of Science ®Google Scholar
• Stringer DM, Zahradka P, Taylor CG. Glucose transporters: cellular links to hyperglycemia in insulin resistance and diabetes. Nutr Rev. 2015;73(3):140–154.
   PubMed Web of Science ®Google Scholar
• Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
   PubMedGoogle Scholar
• Smith SR, Lovejoy JC, Greenway F, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50(4):425–435.
   PubMed Web of Science ®Google Scholar
• Kanaya AM, et al. Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care. 2004;27(6):1375–1380.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Togashi K, Rankinen T, et al. Sex differences in the relationships of abdominal fat to cardiovascular disease risk among normal-weight white subjects. Int J Obes Relat Metab Disord. 2004;28(2):320–323.
   PubMedGoogle Scholar
• Kahn HS, Cheng YJ. Longitudinal changes in BMI and in an index estimating excess lipids among white and black adults in the United States. Int J Obes (Lond). 2008;32(1):136–143.
   PubMedGoogle Scholar